Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

This paper investigates the ability of biomachined lab-on-a-chip (LoC) to perform drug testing of Amphotericin B to the Candida albicans. The chip is made of polydimethyl siloxane (PDMS). Molds are patterned using CNC milling followed by biomachining. CNC milling process creates channel features on the bottom mold, while biomachining forms rough surface on the channels. After the molds are created, LoC can be manufactured using those molds. Hence, contour surface on LoC’s channels is also realized following the mold surface. Later, Candida albicans is seeded on the LoC’s channels for 24 and 48 hours with the continuous flow of Yeast Nitrogen Base (YNB) Sterile. Then, cell viability is tested using 3-[4, 5-dimethylthiazol-2-yl]-2, 5-diphenyltetrazolium (MTT).The result shows that C. albicans could adhere and grow in the LoC channels. Based on this result, drug testing is conducted in the presence and absence of Amphotericin B (Amp B) under two schemes: without (static) and with (dynamic) the continuous flow of YNB Sterile and Amp B. After 48 hour incubation period, C. albicans biofilm of 28.72 % is shown during dynamic scheme, whereas static scheme had C. albicans biofilm of 99.32 % indicating that the dynamic scheme provides a better efficacy compared to the static scheme.

Original publication




Journal article


Journal of biomimetics, biomaterials and biomedical engineering


Trans Tech Publications, Ltd.

Publication Date





24 - 30